[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Editor's Correspondence
January 27, 2003

Potency of Inhaled Corticosteroid Fails to Predict Reduced Emergency Department Visits

Arch Intern Med. 2003;163(2):247-248. doi:10.1001/archinte.163.2.247-a

An interesting secondary finding of the recently reported retrospective analysis by Sin and Man1 was that higher doses of inhaled corticosteroids failed to reduce the frequency of emergency department (ED) visits compared with lower doses.1 My colleagues and I recently performed a similar retrospective analysis stratified by type of inhaled corticosteroid to determine if the more potent agent fluticasone propionate (Flovent; GlaxoSmithKline, Research Triangle Park, NC) reduced ED visits compared with the less potent agents beclomethasone dipropionate (Beclovent; GlaxoSmithKline) and triamcinolone acetonide (Azmacort; Aventis Pharmaceuticals Inc, Bridgewater, NJ).

First Page Preview View Large
First page PDF preview
First page PDF preview